Market Update (NYSE:JNJ): J&J, Glaxo settle U.S. lawsuit over allergy ads

[Reuters – UK Focus] – GlaxoSmithKline Plc (Other OTC: GLAXF – news) has agreed to settle a lawsuit by Johnson & Johnson (NYSE: JNJ – news) accusing it of using false advertising at . . . → Read More: Market Update (NYSE:JNJ): J&J, Glaxo settle U.S. lawsuit over allergy ads Similar Articles: Company Update: Johnson & Johnson (NYSE:JNJ) – Johnson & Johnson to Host Investor Conference Call on First-Quarter Results Market Update (NYSE:JNJ): Johnson & Johnson Announces Formation of New Health and Wellness Platform Designed to Transform Health Care Delivery and Improve the Patient Experience Market Update (NYSE:JNJ): Johnson & Johnson Announces Formation of New Health and Wellness Platform Designed to Transform Health Care Delivery and Improve the Patient Experience